ABSTRACT
Since 2003, the world's developing countries are home to more than 5 billion people thought to be at danger of prolonged consumption of contaminated foods that are aflatoxic according to a number of study efforts conducted in South Africa, Egypt, and other countries in west and east Africa. Additionally, the presence occurrence of aflatoxins and their byproducts in animal tissues used to make food (such as beef and sheep meat) may contaminate human diets. As a result of their increasing prevalence, aflatoxins have recently been identified as a significant public health concern. Aflatoxins are dangerous second-generation byproducts of Aspergillus species. Due to their chemical makeup, the majority of aflatoxins are highly liposoluble substances that can be absorption from the exposed site, such as the gastro-intestinal and respiratory tracts, into the bloodstream, where they can then spread throughout the body and reach various organs, including the liver and kidneys. The primary goals of the study were to monitor and screen for levels of aflatoxin B1 in the Karbala Province using a case-control study. The connection between Aflatoxin B1 concentrations and the common biochemical indicators of liver function as well investigated. How alter liver function by Aflatoxin B1. The study also emphasised the necessity to determine the pathophysiology of AFB1's involvement in the rising number of patients with liver dysfunction. AFB1 levels were quantitated using utilising thin layer chromatography, together with High Pressure liquid chromatography being employed for the quantitative identification (HPLC). In the province of Karbala, an analysis of case-control studies was done to look at the Aflatoxin B1 affects (AFB1) exposure on kidney disease patients. AFB1 levels were quantitated using utilising thin layer chromatography with high-performance liquid chromatography to provide quality results. The evaluations of the samples that tested positive for AFB1 as well as the lipid profile and indicators of liver function tests. The findings indicated that the population under investigation had afflatoxins exposure. AFB1 was found in 100% of individuals with unknown kidney disease (KD) and in 24%, 20%, and 100% of patients with known CKD, respectively. AFB1 concentrations in serum samples ranged from 0.68 to 8.33 ng/mL for patients with questionable KD, 1.21 to For patients, 5.60 ng/mL with known KD, likewise, healthy controls ranged from 0.11 to 1.30 ng/mL. The presence of AFB1 was positively and strongly linked with liver enzymes, specifically ALT and ALP. AFB1 levels among serum samples from KD sufferers and wholesome controls showed a prolonged contact with the poison, suggesting an unknown cause. The evaluation of the biochemical marker of liver functioning supported the effect of AFB1 exposure. This work may help build effective nationwide programmes for tracking AFs exposure. The study also emphasised the necessity to determine the pathophysiology of AFB1's involvement in the rising number of patients with liver dysfunction. Future research is urged to concentrate on more comprehensive topics that cover the entire nation (Iraq)